Condition

Newly Diagnosed clinical trials and research

• 7Clinical trials
• 2Countries

Newest Newly Diagnosed clinical trials

All recruiting trials (7)

• Adding silibinin to standard daunorubicin or idarubicin therapy for newly diagnosed non‑M3 acute myeloid leukemia

  This trial will test whether adding silibinin (a liver‑protecting compound) to standard daunorubicin or idarubicin chemotherapy helps people with newly diagnosed non‑M3 acute myeloid leukemia.

  Recruiting Phase 4 Fujian Medical University Union Hospital · Fuzhou, Fujian · NCT07561892

• Combining Zanubrutinib and Obinutuzumab for Treating Newly Diagnosed Follicular Lymphoma

  This study is testing a new combination of two medications, Zanubrutinib and Obinutuzumab, to see if they can help people with newly diagnosed follicular lymphoma feel better and stay healthy.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06553352

• Comparing different drug combinations for newly diagnosed acute myeloid leukemia

  This study is testing different combinations of drugs to see which one works best for people with newly diagnosed acute myeloid leukemia who can't handle strong chemotherapy.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06532552

• MRD-guided treatment for high-risk newly diagnosed multiple myeloma

  This treatment will test whether combining daratumumab, carfilzomib, lenalidomide and dexamethasone, with or without autologous stem‑cell transplant and MRD‑guided maintenance, can keep high‑risk newly diagnosed multiple myeloma patients free of measurable disease for one year.

  Recruiting Phase 4 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06409702

• Treatment of advanced NK/T-cell lymphoma with selinexor and chemotherapy

  This study tests if adding a new drug called selinexor to standard chemotherapy can help people with advanced NK/T-cell lymphoma feel better and improve their treatment results.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing, Haidian · NCT05833893

• Combination treatment for newly diagnosed acute monocytic leukemia

  This study is testing a new combination treatment for people with newly diagnosed acute monocytic leukemia who can't have intensive chemotherapy to see if it helps them feel better and manage their condition.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05566054

• Understanding barriers to stem cell transplantation in acute leukemia patients

  This study looks at why some patients with acute leukemia, myelodysplastic syndromes, or myeloproliferative neoplasms choose to have or skip stem cell transplants, even when their doctors recommend it.

  Recruiting at 2 sites Memorial Sloan Kettering Cancer Center · Hartford, Connecticut and 2 other locations · NCT02677064

Related topics

Quick answers

How many Newly Diagnosed clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (6 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →